Efficacy of Methylprednisolone pulse therapy versus Infliximab in the treatment of severe flares of chronic polyarthritis

H. C. Nossent, G. Bakland, H. K. Aslaksen, G. Olsen, Bjørn Y. Nordvåg

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Background: To compare short term efficacy of pulse intravenous (iv) Methylprednisolone (MP) versus Infiximab in flares of polyarthritis. Patients-methods: Observational study of consecutive patients admitted with flares of chronic polyarthritis. Treatment consisted of three iv doses of MP 1000 mg on alternate days (MP-group, n=10) or of Infliximab will be 3 mg/kg at baseline, two, and six weeks later (I-group, n=9). DMARD therapy was initiated/continued in all patients. Disease parameters at baseline (t = 0), two weeks (t = 1) and twelve weeks (t = 2) were compared by non-parametric testing. Results: Reductions in disease parameters at both t=1 and t=2, the occurrence of side effects and the proportion of patients reaching ACR 20, 50 or 70% response criteria were similar in both groups. Conclusion: Pulse MP resulted in a symptomatic response similar to Infliximab in our patients. The benefit of MP was observed for up to 3 months.

Original languageEnglish
Pages (from-to)335-339
Number of pages5
JournalScandinavian Journal of Rheumatology
Volume30
Issue number6
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Dive into the research topics of 'Efficacy of Methylprednisolone pulse therapy versus Infliximab in the treatment of severe flares of chronic polyarthritis'. Together they form a unique fingerprint.

Cite this